IF 2.1 4区医学

Cutis Pub Date : 2025-05-01 DOI: 10.12788/cutis.1226

Nicole D Boswell, Gerilyn M Olsen, Olushola L Akinshemoyin Vaughn

引用次数: 0

Evaluating Factors Impacting Hidradenitis Suppurativa Disease Severity in Patients With Darker Skin Types. 深肤色患者化脓性汗腺炎严重程度的影响因素评价

IF 2.1 4区医学

Cutis Pub Date : 2025-05-01 DOI: 10.12788/cutis.1209

Kareena S Garg, Desiree Pinto, Tuan D Le, Lauren Moffatt, Jeffrey Shupp, Cheri Frey, Bonnie C Carney

{"title":"Evaluating Factors Impacting Hidradenitis Suppurativa Disease Severity in Patients With Darker Skin Types.","authors":"Kareena S Garg, Desiree Pinto, Tuan D Le, Lauren Moffatt, Jeffrey Shupp, Cheri Frey, Bonnie C Carney","doi":"10.12788/cutis.1209","DOIUrl":"https://doi.org/10.12788/cutis.1209","url":null,"abstract":"<p><p>Hidradenitis suppurativa (HS) is a debilitating chronic skin disease that has a considerable psychosocial impact on patient quality of life. Despite HS disproportionately affecting individuals with darker skin types, most published HS research features patient cohorts predominantly consisting of White patients. In this retrospective chart review, we aimed to evaluate demographics, comorbidities, and pharmacologic treatments in a predominantly Black patient population that underwent surgical treatment for HS during the period from April 2014 to April 2023 at a regional verified burn center. Our results suggest that Black patients with HS may be impacted by anxiety, depression, and comorbid gastrointestinal disease at higher rates than White patients with HS. Also, the low rates of cigarette smoking yet high rates of marijuana use in our patient population suggest a multifactorial disease pathology, warranting further research. Studies investigating disease pathophysiology, risk factors, and outcomes in HS patients with skin of color (SOC) are imperative to minimizing health care disparity gaps, improving disease outcomes, and providing more equitable health care for all patients.</p>","PeriodicalId":11195,"journal":{"name":"Cutis","volume":"115 5","pages":"140-145"},"PeriodicalIF":2.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144539498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Actinic Keratosis Treatment With Diclofenac Gel 1. 双氯芬酸凝胶治疗光化性角化病

IF 2.1 4区医学

Cutis Pub Date : 2025-05-01 DOI: 10.12788/cutis.1229

Hannah Riva, Radhika Shah, Julie Boisen, Chad D Housewright

引用次数: 0

Low-Dose Oral Naltrexone for Darier Disease. 低剂量口服纳曲酮治疗肾脏病。

IF 2.1 4区医学

Cutis Pub Date : 2025-05-01 DOI: 10.12788/cutis.1220

Vanessa Castro, Oscar Bautista, Gabriela Salgado, Estefanía Fernández, Tullia Cuzzi, Luna Azulay-Abulafia

引用次数: 0

Bridging the Knowledge-Action Gap in Skin Cancer Prevention Among US Military Personnel. 弥合美国军事人员预防皮肤癌的知识和行动差距。